Yale University-Yale New Haven Hospital

New Haven, Connecticut 06510

We've found

2 trials

at this facility

A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

New Haven, CT

A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension

Status: Enrolling, Phase III
Updated: 12/31/1969

from

New Haven, CT

Use our guide to learn which trials are right for you!